LabCompass

Tyler Shugg

Pharmacology, Toxicology and Pharmaceutics · Indiana University

OpenAlex ORCID
Pharmacogenetics and Drug MetabolismCardiac electrophysiology and arrhythmiasIon channel regulation and functionPharmaceutical studies and practicesColorectal Cancer Treatments and Studies

Publications

45

Citations

387

Est. group size

—

Recurring co-author estimate

Active years

17

Publishing since 2010

Research summary
AI-generated

Tyler Shugg studies how genetics and drug interactions affect the heart, with a focus on the electrical signals (ion channels) that control heart rhythm and how medications influence them. The work spans pharmacogenetics (how a person's genes affect their response to drugs), heart failure treatment outcomes, and drug-induced heart rhythm problems. Recent work also explores using real-world patient data to improve dosing in special populations.

Pharmacogenetics and drug metabolismCardiac ion channels and arrhythmiasHeart failure drug response and outcomesDrug-induced cardiac effects and safetyPharmacometrics and real-world data

Publication activity has grown over the last decade, rising from a few papers per year early on to a steady output of roughly six per year in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.8/year recently
172018: 3 publications182019: 3 publications192020: 4 publications202021: 1 publication212022: 7 publications7222023: 7 publications7232024: 6 publications242025: 6 publications252026: 3 publications26
Recent publications
Publishes in
  • Clinical Pharmacology & Therapeutics×5
  • medRxiv×3
  • JCO Precision Oncology×2
  • Frontiers in Oncology×2
  • The Journal of Clinical Pharmacology×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile